QR-koodi

Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial

Abstract Background Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. Methods We prospectively collected CTC data from patients with operable non-metastatic esophageal canc...

Täydet tiedot

Tallennettuna:
Päätekijät: Edward Yu, Alison L. Allan, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Lori E. Lowes, David A. Palma, Jacques Raphael, Mark D. Vincent, George B. Rodrigues, Dalilah Fortin, Richard I. Inculet, Eric Frechette, Joel Bierer, Jeffery Law, Jawaid Younus, Richard A. Malthaner
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2022-07-01
Sarja:BMC Cancer
Aiheet:
Circulating tumor cells
Prognostic
Non-metastatic
Esophageal cancer
Linkit:https://doi.org/10.1186/s12885-022-09846-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia